These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 11120755)

  • 21. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.
    Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Tatamiya M; Nakao N; Yoshida N; Nakayama K
    Immunol Lett; 2003 Sep; 88(3):193-8. PubMed ID: 12941478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
    Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors.
    Wei S; Teitelbaum SL; Wang MW; Ross FP
    Endocrinology; 2001 Mar; 142(3):1290-5. PubMed ID: 11181547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
    J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.
    Matsumoto M; Sudo T; Maruyama M; Osada H; Tsujimoto M
    FEBS Lett; 2000 Dec; 486(1):23-8. PubMed ID: 11108836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
    Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
    J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1).
    Kwak HB; Jin HM; Ha H; Kang MJ; Lee SB; Kim HH; Lee ZH
    Biochem Biophys Res Commun; 2005 May; 330(4):1080-6. PubMed ID: 15823554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
    Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
    Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
    Ogasawara T; Katagiri M; Yamamoto A; Hoshi K; Takato T; Nakamura K; Tanaka S; Okayama H; Kawaguchi H
    J Bone Miner Res; 2004 Jul; 19(7):1128-36. PubMed ID: 15176996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
    Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y
    Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation.
    Park EK; Kim MS; Lee SH; Kim KH; Park JY; Kim TH; Lee IS; Woo JT; Jung JC; Shin HI; Choi JY; Kim SY
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1472-80. PubMed ID: 15555594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo.
    Kitaura H; Sands MS; Aya K; Zhou P; Hirayama T; Uthgenannt B; Wei S; Takeshita S; Novack DV; Silva MJ; Abu-Amer Y; Ross FP; Teitelbaum SL
    J Immunol; 2004 Oct; 173(8):4838-46. PubMed ID: 15470024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
    Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB
    Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell adhesion signaling regulates RANK expression in osteoclast precursors.
    Mochizuki A; Takami M; Miyamoto Y; Nakamaki T; Tomoyasu S; Kadono Y; Tanaka S; Inoue T; Kamijo R
    PLoS One; 2012; 7(11):e48795. PubMed ID: 23139818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis.
    Kanazawa K; Azuma Y; Nakano H; Kudo A
    J Bone Miner Res; 2003 Mar; 18(3):443-50. PubMed ID: 12619928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
    Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
    Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.